- Home
- AGMB vs TIPT Comparison
AGMB vs TIPT Comparison
Compare AGMB & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGMB | TIPT |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.7M | 672.9M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AGMB | TIPT |
|---|---|---|
| Price | $13.29 | $18.49 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 89.6K | ★ 201.7K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | ★ $488,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.86 | N/A |
| P/E Ratio | ★ N/A | $53.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.75 | $15.49 |
| 52 Week High | $17.82 | $27.38 |
Technical Indicators
Market Signals| Indicator | AGMB | TIPT |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 59.83 |
| Support Level | $9.54 | $17.30 |
| Resistance Level | $14.19 | $18.72 |
| Average True Range (ATR) | 1.05 | 0.37 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 29.81 | 94.39 |
Price Performance
Historical ComparisonAbout AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.